Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

Related Articles by Review for PubMed (Select 12234503)

1.

A randomised comparison of bicalutamide ('Casodex') 150 mg versus placebo as immediate therapy either alone or as adjuvant to standard care for early non-metastatic prostate cancer. First report from the Scandinavian Prostatic Cancer Group Study No. 6.

Iversen P, Tammela TL, Vaage S, Lukkarinen O, Lodding P, Bull-Njaa T, Viitanen J, Hoisaeter P, Lundmo P, Rasmussen F, Johansson JE, Persson BE, Carroll K; Scandinavian Prostatic Cancer Group (SPCG).

Eur Urol. 2002 Sep;42(3):204-11.

PMID:
12234503
2.

Emerging role of adjuvant hormonal therapy.

Mcleod DG.

Urology. 2002 Sep;60(3 Suppl 1):13-20; discussion 21. Review.

PMID:
12231039
3.

Bicalutamide 150mg: a review of its use in the treatment of locally advanced prostate cancer.

Wellington K, Keam SJ.

Drugs. 2006;66(6):837-50. Review. Erratum in: Drugs. 2006;66(15):1987.

PMID:
16706554
4.

Bicalutamide (Casodex) in the treatment of prostate cancer: history of clinical development.

Kolvenbag GJ, Blackledge GR, Gotting-Smith K.

Prostate. 1998 Jan 1;34(1):61-72. Review.

PMID:
9428389
5.

An evaluation of bicalutamide in the treatment of prostate cancer.

Schellhammer PF.

Expert Opin Pharmacother. 2002 Sep;3(9):1313-28. Review.

PMID:
12186624
6.
7.

Bicalutamide: in early-stage prostate cancer.

Carswell CI, Figgitt DP.

Drugs. 2002;62(17):2471-79; discussion 2480-1. Review.

PMID:
12421104
8.

An evaluation of bicalutamide in the treatment of prostate cancer.

Schellhammer PF, Davis JW.

Clin Prostate Cancer. 2004 Mar;2(4):213-9. Review.

PMID:
15072604
9.

Bicalutamide monotherapy for early stage prostate cancer: an update.

Iversen P.

J Urol. 2003 Dec;170(6 Pt 2):S48-52; discussion S52-4. Review.

PMID:
14610410
10.

Treatment of locally advanced prostate cancer--a new role for antiandrogen monotherapy?

Abrahamsson PA.

Eur Urol. 2001;39 Suppl 1:22-8. Review.

PMID:
11114597
11.

[The role of bicalutamide in the treatment of prostate cancer].

Stav SY, Segal G.

Harefuah. 2002 Apr;141(4):379-83, 408, 407. Review. Hebrew.

PMID:
12017896
12.

[The use of Casodex (bicalutamide) in the treatment of disseminated prostatic cancer].

Sivko AV, Prokhorov AV.

Urol Nefrol (Mosk). 1997 May-Jun;(3):49-52. Review. Russian. No abstract available.

PMID:
9245060
13.

Adjuvant hormonal treatment - the bicalutamide early prostate cancer program.

Wirth MP, Hakenberg OW, Froehner M.

Front Radiat Ther Oncol. 2008;41:39-48. doi: 10.1159/000139877. Review.

PMID:
18544984
14.

Adjuvant hormonal treatment for prostate cancer: the bicalutamide early prostate cancer program.

Wirth MP, Froehner M.

Oncology. 2003;65 Suppl 1:1-4. Review.

PMID:
12949426
15.

Casodex (bicalutamide): overview of a new antiandrogen developed for the treatment of prostate cancer.

Blackledge GR, Cockshott ID, Furr BJ.

Eur Urol. 1997;31 Suppl 2:30-9. Review.

PMID:
9074908
16.
17.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

18.

Antiandrogen monotherapy: indications and results.

Iversen P.

Urology. 2002 Sep;60(3 Suppl 1):64-71. Review.

PMID:
12231053
19.

Maximal androgen blockade for advanced prostate cancer.

Klotz L.

Best Pract Res Clin Endocrinol Metab. 2008 Apr;22(2):331-40. doi: 10.1016/j.beem.2008.01.004. Review.

PMID:
18471790
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk